Skip to main content
. 2021 Feb 22;11(2):e046791. doi: 10.1136/bmjopen-2020-046791

Table 2.

Primary outcomes

Proportion (%), unless otherwise specified Group 1
(n=15)
Group 2
(n=15)
Group 3
(n=16)
Total
(n=46)
Number of diaries with some data points entered by participant by end of participant follow-up 15
(100%)
13
(86.7%)
13
(81.3%)
41
(89.1%)
Number of diaries fully completed by participant by end of participant follow-up 13
(86.7%)
10
(66.7%)
9
(56.3%)
32
(69.6%)
Paper diaries issued due to failure of electronic diary 0
(0%)
0
(0%)
0
(0%)
0
(0%)
Number randomised as a proportion of the target recruitment number 46/45
(102.2%)
Number randomised as a proportion of invited participants 46/120
(38.3%)
Number randomised as a proportion of eligible participants 46/67
(68.7%)
 No of patients invited 120
 No of patients eligible 67
 No of participants enrolled 15 15 16 46
 No of participants randomised 15 15 16 46
 No of recruited per month (n) 9.2
Number of participants lost to follow-up 0
(0%)
2
(13.3%)
1
(6.3%)
3
(6.5%)
Number of participants withdrawing from study 0
(0%)
0
(0%)
2
(12.5%)
2
(4.4%)
Side effects or problems related to cranberry consumption
 Yes 0/13
(0%)
0/10
(0%)
1/11
(9.1%)
1/34 (2.9%)
 No 1/13
(7.7%)
10/10
(100%)
10/11 (90.9%) 21/34 (61.8%)
 Not applicable 12/13 (92.3%) 0/10
(0%)
0/11
(0%)
12/34 (35.3%)
 Missing 2/15 5/15 5/16 12/46
Problems completing the electronic diary
 No problem 14/14 (100%) 9/10
(90%)
9/11
(81.8%)
32/35 (91.4%)
 Some problems 0/14
(0%)
1/10
(10%)
2/11
(18.2%)
3/35 (8.6%)
 Lots of problems 0/14
(0%)
0/10
(0%)
0/11
(0%)
0/35
(0%)
 Missing 1/15 5/15 5/16 11/46
Problems using the scale of 0–50
 No problem 12/14 (85.7%) 9/9
(100%)
10/12 (83.3%) 31/35 (88.6%)
 Some problems 2/14 (14.3%) 0/9
(0%)
2/12
(16.7%)
4/35 (11.4%)
 Lots of problems 0/14
(0%)
0/9
(0%)
0/12
(0%)
0/35
(0%)
 Missing 1/15 6/15 4/16 11/46
Proportion of invited GP practices agreeing to participate in the trial 5/5
(100%)
Proportion of invited GP practices opened and recruiting to the trial 4/5
(80%)
Acceptability of the study to participants and recruiters, participants’ experience of having a UTI and thoughts on self-help for UTIs Interviews with trial participants and recruiters will be reported elsewhere.

Group 1—immediate antibiotics alone (control); group 2—immediate antibiotics and immediate cranberry; group 3—immediate cranberry and delayed antibiotics.

GP, general practitioner; UTI, urinary tract infection.